<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Hansa Biopharma — November 2025]]></title><description><![CDATA[<p dir="auto">Ryk tre felter tilbage…..du er landet på Rådhuspladsen. Er det tid til refill?</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400768/hansa-biopharma-november-2025</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 02:17:22 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400768.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 07 Nov 2025 16:54:49 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 27 Nov 2025 04:50:54 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> endnu et fint kursmål langt over dagens kurs det har vi set tit men det hjælper ikke en skid kursen hænger fast her nede i intervallet 25-40 det har den kørt i de sidste<br />
14 mdr.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007967</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007967</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 27 Nov 2025 04:50:54 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Wed, 26 Nov 2025 13:43:46 GMT]]></title><description><![CDATA[<p dir="auto">26/11 Leerink Partners Initiates Coverage of Hansa Biopharma with Outperform Rating, Target Price Set at SEK 102 - BN<br />
<a href="https://www.marketscreener.com/news/leerink-partners-initiates-coverage-of-hansa-biopharma-with-outperform-rating-target-price-set-at-s-ce7d5ed2d180f020" rel="nofollow ugc">https://www.marketscreener.com/news/leerink-partners-initiates-coverage-of-hansa-biopharma-with-outperform-rating-target-price-set-at-s-ce7d5ed2d180f020</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007968</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007968</guid><dc:creator><![CDATA[Cupcake]]></dc:creator><pubDate>Wed, 26 Nov 2025 13:43:46 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 21 Nov 2025 13:09:56 GMT]]></title><description><![CDATA[<p dir="auto">5,12 % af aktierne er shortede. Den bliver dyr, når de skal ud af den samtidig.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007966</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007966</guid><dc:creator><![CDATA[Henrikhot]]></dc:creator><pubDate>Fri, 21 Nov 2025 13:09:56 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 21 Nov 2025 13:08:56 GMT]]></title><description><![CDATA[<p dir="auto">Shortede aktier i Hansa B. <a href="https://shortregister.com/se/hansa-biopharma-hnsa?utm_source=chatgpt.com" rel="nofollow ugc">https://shortregister.com/se/hansa-biopharma-hnsa?utm_source=chatgpt.com</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007965</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007965</guid><dc:creator><![CDATA[Henrikhot]]></dc:creator><pubDate>Fri, 21 Nov 2025 13:08:56 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 21 Nov 2025 12:58:33 GMT]]></title><description><![CDATA[<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://journals.lww.com/transplantjournal/fulltext/2025/08000/belgian_consensus_guidelines_within_eurotransplant.6.aspx">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://journals.lww.com/transplantjournal/fulltext/2025/08000/belgian_consensus_guidelines_within_eurotransplant.6.aspx" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://journals.lww.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(journals.lww.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007961</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007961</guid><dc:creator><![CDATA[Henrikhot]]></dc:creator><pubDate>Fri, 21 Nov 2025 12:58:33 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 21 Nov 2025 12:58:08 GMT]]></title><description><![CDATA[<p dir="auto">New Belgian consensus guidelines outline when and how to use imlifidase for desensitization, offering a realistic pathway to transplantation for patients who would otherwise remain on dialysis for years—or never be transplanted at all.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007963</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007963</guid><dc:creator><![CDATA[Henrikhot]]></dc:creator><pubDate>Fri, 21 Nov 2025 12:58:08 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 21 Nov 2025 12:57:39 GMT]]></title><description><![CDATA[<p dir="auto">Highly sensitized kidney patients (PRA &gt;85%) face extremely low chances of receiving a compatible donor organ, even within priority programs like Eurotransplant’s Acceptable Mismatch system.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007959</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007959</guid><dc:creator><![CDATA[Henrikhot]]></dc:creator><pubDate>Fri, 21 Nov 2025 12:57:39 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 14 Nov 2025 12:38:03 GMT]]></title><description><![CDATA[<p dir="auto">Optimistic Buy Rating for Hansa Biopharma AB: Imlifidase’s Potential in Kidney Transplantation Highlighted by Key Opinion Leaders</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-hansa-biopharma-ab-imlifidases-potential-in-kidney-transplantation-highlighted-by-key-opinion-leaders-ratings">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-hansa-biopharma-ab-imlifidases-potential-in-kidney-transplantation-highlighted-by-key-opinion-leaders-ratings" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.tipranks.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.tipranks.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007960</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007960</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 14 Nov 2025 12:38:03 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Fri, 14 Nov 2025 12:37:54 GMT]]></title><description><![CDATA[<p dir="auto">Analyst Douglas Tsao of H.C. Wainwright reiterated a Buy rating on Hansa Biopharma AB, retaining the price target of SEK132.00.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007964</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007964</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 14 Nov 2025 12:37:54 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 13 Nov 2025 13:29:01 GMT]]></title><description><![CDATA[<p dir="auto">"relatively unsuccessful" er vist en meget pæn formulering <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007962</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007962</guid><dc:creator><![CDATA[collersteen]]></dc:creator><pubDate>Thu, 13 Nov 2025 13:29:01 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 13 Nov 2025 05:32:45 GMT]]></title><description><![CDATA[<p dir="auto">"In summary, we think the KOL event underlines the high unmet need that imlifidase satisfies and gives us stronger conviction in our sales forecast. We believe the market does not fully appreciate the high likelihood of approval (barring any CRL) and likely rapid uptake of imlifidase in the US, basing its expectations on the relatively unsuccessful European sales trajectory."</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007954</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007954</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 13 Nov 2025 05:32:45 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 13 Nov 2025 05:32:36 GMT]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma: Notes on KOL Comments on ConfideS</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.redeye.se/research/1138601/hansa-biopharma-notes-on-kol-comments-on-confides">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.redeye.se/research/1138601/hansa-biopharma-notes-on-kol-comments-on-confides" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.redeye.se/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.redeye.se)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007955</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007955</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 13 Nov 2025 05:32:36 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 13 Nov 2025 05:32:21 GMT]]></title><description><![CDATA[<p dir="auto">Før daggry er mørket stærkest, godt du holder ved <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007956</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007956</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Thu, 13 Nov 2025 05:32:21 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Thu, 13 Nov 2025 04:25:34 GMT]]></title><description><![CDATA[<p dir="auto">exitnu det gør jeg også har så mange at jeg vil slå bunden ud af min økonomi hvis jeg skulle tage det kæmpe tab <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007957</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007957</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 13 Nov 2025 04:25:34 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Wed, 12 Nov 2025 11:37:23 GMT]]></title><description><![CDATA[<p dir="auto">Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://www.hansabiopharma.com/media/press-releases/2025/upcoming-kol-call-today-insights-on-clinical-practice-and-imlifidase-phase-3-results/" title="Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results | Hansa Biopharma">
<img src="https://www.hansabiopharma.com/images/cc2675d4-702d-4061-a6b9-32744d01d973/sp/hansa_color_highres.png" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.hansabiopharma.com/media/press-releases/2025/upcoming-kol-call-today-insights-on-clinical-practice-and-imlifidase-phase-3-results/">
Upcoming KOL Call today: Insights on clinical practice and imlifidase Phase 3 Results | Hansa Biopharma
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.hansabiopharma.com/media/press-releases/2025/upcoming-kol-call-today-insights-on-clinical-practice-and-imlifidase-phase-3-results/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.hansabiopharma.com/favicons/favicon-32x32.png" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>









<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.hansabiopharma.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007951</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007951</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Wed, 12 Nov 2025 11:37:23 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Wed, 12 Nov 2025 11:35:57 GMT]]></title><description><![CDATA[<p dir="auto">Hansa Biopharma AB: Kommande KOL-samtal idag: Insikter om klinisk praxis och fas 3- resultaten med imlifidase</p>
<p dir="auto">Eventet finder sted i dag, onsdag den 12. november 2025 kl. 15.00.</p>
<p dir="auto">Link til det virtuelle møde: <a href="https://lifescievents.com/event/gl39mp2j/" rel="nofollow ugc">https://lifescievents.com/event/gl39mp2j/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007958</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007958</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Wed, 12 Nov 2025 11:35:57 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Wed, 12 Nov 2025 09:23:24 GMT]]></title><description><![CDATA[<p dir="auto">LP90 - bare hold fast!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007953</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007953</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Wed, 12 Nov 2025 09:23:24 GMT</pubDate></item><item><title><![CDATA[Reply to Hansa Biopharma — November 2025 on Tue, 11 Nov 2025 14:31:54 GMT]]></title><description><![CDATA[<p dir="auto">Fatter ikke den her case fin emission på 672 Mill til kurs 39,5 for 5 uger siden og Jefferies kursmål på 100 for 3 uger siden og vi er handlet ned i kurs 26 og der har været et fint insiderkøb og alligevel er short steget fra ca. 3,7 til 5 % hvad ser de som ikke er oplyst nogen der har de visse ord ???</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8007952</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8007952</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 11 Nov 2025 14:31:54 GMT</pubDate></item></channel></rss>